Long-term outcomes of thalidomide in refractory Crohn's disease
Author:
Affiliation:
1. Cedars-Sinai Medical Center; Los Angeles CA USA
Publisher
Wiley
Subject
Pharmacology (medical),Gastroenterology,Hepatology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13057/fullpdf
Reference34 articles.
1. Inflammatory bowel disease;Abraham;N Engl J Med,2009
2. Crohn's disease;Baumgart;Lancet,2012
3. New therapies for inflammatory bowel disease: from the bench to the bedside;Danese;Gut,2012
4. Long-term outcome of treatment with infliximab in 614 patients with Crohn's disease: results from a single-centre cohort;Schnitzler;Gut,2009
5. Durability of infliximab in Crohn's disease: a single-center experience;Gonzaga;Inflamm Bowel Dis,2009
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. What is the appropriate treatment strategy for cryptogenic multifocal ulcerative stenosing enteritis? A single-center experience from China;Frontiers in Medicine;2022-08-11
2. The efficacy and safety of thalidomide in the treatment of refractory Crohn's disease in adults: a double-center, double-blind, randomized–controlled trial;Gastroenterology Report;2022-01-01
3. Chinese consensus on diagnosis and treatment in inflammatory bowel disease (2018, Beijing);Journal of Digestive Diseases;2021-06
4. CYP2C19 polymorphism has no correlation with the efficacy and safety of thalidomide in the treatment of immune‐related bowel disease;Journal of Digestive Diseases;2020-02
5. Thalidomide-induced sinus bradycardia in Crohn’s disease: case report and literature review;Journal of International Medical Research;2019-03-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3